+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Theranostics: Global Markets

  • ID: 5178170
  • Report
  • October 2020
  • Region: Global
  • 160 Pages
  • BCC Research
The Global Market for Theranostics Should Grow from $80.4 Billion in 2020 to $129.8 Billion by 2025, at a CAGR of 10.1%

FEATURED COMPANIES

  • Astrid Pharma
  • Canon Medical Systems
  • Clarity Pharmaceuticals
  • Foundation Medicine
  • Hitachi
  • Perkinelmer
  • MORE

The global market for theranostics should grow from $80.4 billion in 2020 to $129.8 billion by 2025, at a compound annual growth rate (CAGR) of 10.1% for the period of 2020-2025.

  • The oncology segment market for theranostics should grow from $73.1 billion in 2020 to $119.7 billion by 2025, at a CAGR of 10.4% for the period of 2020-2025.
  • The RIIDs segment market for theranostics should grow from $2 billion in 2020 to $2.8 billion by 2025, at a CAGR of 7.1% for the period of 2020-2025.

During the past 20 years, the market for theranostics has been growing steadily driven in particular by companion diagnostic therapies resulting in a market that is currently valued at more than $80 billion.

The main goal of this report is to provide an updated review of the most important advances in theranostic technology, with a focus on those products, applications, and strategies that will be instrumental to market growth during the next five years. In addition, a current and detailed assessment of the market for theranostics is offered, including an objective analysis of industry and technological trends, and prospects for future growth.

Specifically, the major objectives of this study are to:

  • Provide a detailed review of theranostics, focusing on types of products, properties, materials, imaging technologies and applications.
  • Highlight new technological developments related to theranostics, while outlining current technical issues.
  • Review existing fields of application for theranostics and examine emerging applications.
  • Estimate current global markets for theranostics by category, product type, application, and region, with growth forecasts through 2025 for each market segment.
  • Identify important technology and industry trends within each market segment.
  • Offer an updated review of current industry players, including manufacturers of products used in theranostics, reagents, and instrumentation for theranostics research, as well as suppliers of theranostic-related services, technology developers, and future market participants.
  • Provide a description of the most relevant research and development activities.
  • Determine trends in recently issued U.S. patents.

Scope of the Report

This report provides an updated review of theranostics, including materials, equipment, and strategies, and identifies current and emerging applications for theranostic products.

The publisher delineates the current market status for theranostics, defines trends, and presents growth forecasts for the next five years. The theranostics market is analyzed based on the following segments: category, product type, application, and region. In addition, technological issues, including key events and the latest developments, are discussed.

More specifically, the market analysis is divided into five sections.

In the first section, an introduction to the topic and a historical review of theranostic technology are provided, including an outline of recent events. In this section, current and emerging applications for theranostics are also identified and grouped in segments (oncology, cardiovascular diseases, respiratory diseases, neurological disorders, and others).

The second section provides a technological review of theranostics. This section offers a detailed description of theranostic materials and equipment, their properties, configurations, and typical strategies used in theranostics. This section concludes with an analysis of the most important technological developments since 2018, including examples of significant patents recently issued or applied for. The chapter ends with an highlight of the most active research organizations operating in this field and their activities.

The third section entails a global market analysis for theranostics. Global revenues (sales data in millions of dollars) are presented for each segment (category, product type, application, and region), with actual data referring to the years 2018 and 2019, and estimates for 2020. Revenues are at the manufacturing level. The analysis of current revenues for theranostics is followed by a detailed presentation of market growth trends, based on industry growth, technological trends, and regional trends. The third section concludes by providing projected revenues for theranostics within each segment, together with forecast CAGRs for the period 2020 through 2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.

In the fourth section of the study, which covers global industry structure, the report offers a list of the leading suppliers of theranostic technologies, together with a description of their products. The analysis includes a description of the geographical distribution of these firms and an evaluation of other key industry players. Detailed company profiles of the top players are also provided.

The fifth and final section includes an analysis of recently issued U.S. patents, with a summary of patents related to theranostic materials, processes, and applications. Patent analysis is performed by region, country, assignee, patent category, material type, and application.

The report includes:

  • 53 data tables and 20 additional tables
  • An updated overview of the global markets for theranostics with emphasis on types of products, properties, materials, imaging technologies, and applications
  • Analyses of the global market trends with data from 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Estimation of the current and potential market size for theranostics, and market share analysis on the basis of category, product type, application, and geographical region
  • Highlights of new technological developments related to theranostics, while outlining current technical issues
  • Review existing fields of application for theranostics and examination of emerging applications such as macular degeneration, gynecology, cutaneous hypersensitivity, and cardio-respiratory medicines
  • Identification of important technology and industry trends within each market segment with a holistic review of current industry players, including manufacturers of products used in theranostics, reagents, and instrumentation for theranostics research, as well as suppliers of theranostics-related services, technology developers, and future market participants
  • Assessment of latest technological developments and the most relevant global R&D activities related to theranostics, resulting in the issuance of patents
  • Analysis of the recently issued U.S. patents, with a summary of patents related to theranostic materials, processes, and applications
  • Comprehensive company profiles of the major market players, including Bayer, Bristol Myers Squibb, GE Healthcare, GlaxoSmithKline (GSK) and Hitachi
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Astrid Pharma
  • Canon Medical Systems
  • Clarity Pharmaceuticals
  • Foundation Medicine
  • Hitachi
  • Perkinelmer
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Methodology and Information Sources
  • Market Breakdown
  • Analyst's Credentials
  • Custom Research

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Theranostics
  • The Diagnostic and Therapeutic Product Market
  • Milestones in the History of Theranostics and Recent Events
  • Current and Emerging Applications for Theranostics
  • Oncology
  • Cardiovascular Disorders
  • Respiratory, Inflammatory and Infectious Diseases
  • Neurological Disorders
  • Tissue Engineering
  • Others

Chapter 4 Technology

  • Introduction
  • Strategies, Methods, Materials and Equipment for Theranostics
  • Diagnostic Functions
  • Therapeutic Functions
  • Theranostic Agents
  • Hydrogels
  • Microparticles
  • Latest Technological Developments, 2018 to Present
  • Oxygen Reactive Polymers for Traumatic Brain Injuries
  • Graphene Quantum Dots for Targeted Therapies
  • Theranostic Agent for Photoacoustic Imaging and Photothermal Therapy
  • Theranostic Agents for Metastatic Tumors
  • Other Relevant R&D Activities

Chapter 5 Global Markets

  • Analysis Outline
  • Global Market Summary
  • Current Market Status
  • Market by Category
  • Market by Product Type
  • Market by Application
  • Market by Region
  • Market Growth Trends
  • Oncology
  • Cardiovascular Diseases
  • Respiratory, Inflammatory and Infectious Diseases
  • Neurological Disorders
  • Other Applications
  • Other Technological Trends
  • Regional Trends
  • Market Forecast
  • Market by Category
  • Market by Product Type
  • Market by Application
  • Market by Region

Chapter 6 Global Industry Structure and Company Profiles

  • Leading Suppliers of Theranostic Technologies
  • Distribution of Leading Suppliers by Product Type and Region
  • Other Industry Players
  • Company Profiles
  • Astrid Pharma
  • Bayer
  • Bristol Myers Squibb
  • Canon Medical Systems
  • Caris Life Sciences
  • Carl Zeiss
  • Clarity Pharmaceuticals
  • Curium Pharma
  • Encapsula Nanosciences
  • Foundation Medicine
  • GE Healthcare
  • GlaxoSmithKline
  • Hitachi
  • Magforce
  • Merck KGaA
  • Perkinelmer
  • Pfizer
  • Roche
  • Siemens Healthcare
  • Thermo Fisher Scientific

Chapter 7 Patent Analysis

  • Introduction
  • Summary of Recently Awarded Patents
  • General Trends
  • Trends by Country and Region
  • Trends by Assignee
  • Trends by Patent Category
  • Trends by Material Type
  • Trends by Application

List of Tables
Summary Table: Global Market for Theranostics, by Application, Through 2025
Table 1: Global Market for Diagnostic and Therapeutic Products, Through 2025
Table 2: Global Market for Diagnostic and Therapeutic Products, by Country/Region, Through 2025
Table 3: Technological Milestones for Theranostics
Table 4: Global Patent Applications and Patents Related to Theranostics, 1990-2019
Table 5: Global Number of Deaths, by Cancer Type, 2018
Table 6: Global Number of Cancer Deaths, by Country/Region, 2018
Table 7: Applications of Theranostics in different Cancer Types, 2020
Table 8: Global Number of Cardiovascular Disease Deaths, by Country/Region, 2018
Table 9: Applications of Theranostics in Cardiovascular Diseases, 2020
Table 10: Applications of Theranostics for Respiratory, Inflammatory and Infectious Diseases, 2020
Table 11: Applications of Theranostics for Neurological Disorders, 2020
Table 12: Applications of Theranostics in Tissue Engineering, 2020
Table 13: Other Applications of Theranostics, 2020
Table 14: The Nanotechnology Industry, 2020
Table 15: Other Relevant R&D Activities, 2020
Table 16: Drivers, Restraints, Challenges, and Opportunities for the Theranostics Market
Table 17: Global Market for Theranostics, by Application, Through 2025
Table 18: Global Market for Theranostics, by Category, Through 2020
Table 19: Global Market for Theranostics, by Product Type, Through 2020
Table 20: Global Market for Therapeutic Agents Used with Companion Diagnostics, by Drug Type, Through 2020
Table 21: Global Market for Theranostics, by Application, Through 2020
Table 22: Global Market for Cancer Theranostics, by Cancer Type, Through 2020
Table 23: Global Market for Theranostics, by Country/Region, Through 2020
Table 24: Global Market for Breast Cancer Drugs, by Country/Region, Through 2025
Table 25: Global Market for Lung Cancer Drugs, by Country/Region, Through 2025
Table 26: Global Market for Prostate Cancer Drugs, by Country/Region, Through 2025
Table 27: Global Market for Colorectal Cancer Drugs, by Country/Region, Through 2025
Table 28: Global Market for Ovarian Cancer Drugs, by Country/Region, Through 2025
Table 29: Global Market for Liver Cancer Drugs, by Country/Region, Through 2025
Table 30: Global Market for Pancreatic Cancer Drugs, by Country/Region, Through 2025
Table 31: Global Market for Blood Cancer Drugs, by Country/Region, Through 2025
Table 32: Global Market for Cancer Drugs, by Country/Region, Through 2025
Table 33: Global Market for Cardiovascular Drugs, by Category, Through 2025
Table 34: Global Market for Antihypertensive Drugs, by Type, Through 2025
Table 35: Global Market for Antihyperlipidemic Drugs, by Type, Through 2025
Table 36: Global Market for Blood Modifiers, by Type, Through 2025
Table 37: Global Market for Other Cardiovascular Drugs, by Type, Through 2025
Table 38: Global Market for Cardiovascular Drugs, by Country/Region, Through 2025
Table 39: Global Market for Drugs for the Respiratory System, by Category, Through 2025
Table 40: Global Market for Drugs for the Respiratory System, by Country/Region, Through 2025
Table 41: Global Market for Therapies for Alzheimer’s Disease, by Country/Region, Through 2025
Table 42: Global Market for Epilepsy Therapeutics, by Country/Region, Through 2025
Table 43: Global Market for Traumatic Brain Injury Treatments, by Country/Region, Through 2025
Table 44: Global Market for Diabetes Drugs, by Country/Region, Through 2025
Table 45: Global Market for Gastrointestinal Drugs, by Country/Region, Through 2025
Table 46: Global Market for Implantable Devices, by Country/Region, Through 2025
Table 47: Global Market for Implantable Devices, by Type, Through 2025
Table 48: Global Market for Nanomedicine, by Country/Region, Through 2025
Table 49: Global Market for Nuclear Medicine, by Country/Region, Through 2025
Table 50: Global Market for Artificial Intelligence, by Country/Region, Through 2025
Table 51: Global Market for Artificial Intelligence, by Application, Through 2025
Table 52: Global Market for Theranostics, by Category, Through 2025
Table 53: Global Market for Theranostics, by Product Type, Through 2025
Table 54: Global Market for Therapeutic Agents Used with Companion Diagnostics, by Drug Type, Through 2025
Table 55: Global Market for Theranostics, by Application, Through 2025
Table 56: Global Market for Cancer Theranostics, by Cancer Type, Through 2025
Table 57: Global Market for Theranostics, by Country/Region, Through 2025
Table 58: Leading Suppliers of Theranostic Technologies, 2020
Table 59: Leading Suppliers of Diagnostic Tests, 2020
Table 60: Leading Suppliers of Therapeutic Agents, 2020
Table 61: Leading Suppliers of Imaging Systems, 2020
Table 62: Leading Suppliers of Theranostic Agents, 2020
Table 63: Leading Suppliers of Theranostic Technologies, by Product Type and Country/Region, 2020
Table 64: Other Relevant Industry Players, 2020
Table 65: U.S. Patents Related to Theranostics, 2020
Table 66: U.S. Patent Trend of Theranostics, 2016-2020
Table 67: U.S. Patents Related to Theranostics, by Country/Region, 2020
Table 68: U.S. Patents Related to Theranostics, by Country, 2020
Table 69: Assignees of U.S. Patents Related to Theranostics, 2020
Table 70: U.S. Patents Related to Theranostics, by Patent Category, 2020
Table 71: U.S. Patents Related to Theranostics, by Material Type, 2020
Table 72: U.S. Patents Related to Theranostics, by Application, 2020

List of Figures
Summary Figure: Global Market for Theranostics, by Application, 2018-2025
Figure 1: Global Market Shares of Diagnostic and Therapeutic Products, 2025
Figure 2: Global Market Shares of Diagnostic and Therapeutic Products, by Country/Region, 2025
Figure 3: Global Patent Applications and Patent Related to Theranostics, 1990-2019
Figure 4: Global Market for Theranostics, by Application, 2018-2025
Figure 5: Global Market Shares of Theranostics, by Category, 2020
Figure 6: Global Market Shares of Theranostics, by Product Type, 2020
Figure 7: Global Market Shares of Therapeutic Agents Used with Companion Diagnostics, by Drug Type, 2020
Figure 8: Global Market Shares of Theranostics, by Application, 2020
Figure 9: Global Market Shares of Cancer Theranostics, by Cancer Type, 2020
Figure 10: Global Market Shares of Theranostics, by Country/Region, 2020
Figure 11: Global Market Shares of Breast Cancer Drugs, by Country/Region, 2025
Figure 12: Global Market Shares of Lung Cancer Drugs, by Country/Region, 2025
Figure 13: Global Market Shares of Prostate Cancer Drugs, by Country/Region, 2025
Figure 14: Global Market Shares of Colorectal Cancer Drugs, by Country/Region, 2025
Figure 15: Global Market Shares of Ovarian Cancer Drugs, by Country/Region, 2025
Figure 16: Global Market Shares of Liver Cancer Drugs, by Country/Region, 2025
Figure 17: Global Market Shares of Pancreatic Cancer Drugs, by Country/Region, 2025
Figure 18: Global Market Shares of Blood Cancer Drugs, by Country/Region, 2025
Figure 19: Global Market Shares of Cancer Drugs, by Country/Region, 2025
Figure 20: Global Market Shares of Cardiovascular Drugs, by Category, 2025
Figure 21: Global Market Shares of Antihypertensive Drugs, by Type, 2025
Figure 22: Global Market Shares of Antihyperlipidemic Drugs, by Type, 2025
Figure 23: Global Market Shares of Blood Modifiers, by Type, 2025
Figure 24: Global Market Shares of Other Cardiovascular Drugs, by Type, 2025
Figure 25: Global Market Shares of Cardiovascular Drugs, by Country/Region, 2025
Figure 26: Global Market Shares of Drugs for the Respiratory System, by Category, 2025
Figure 27: Global Market Shares of Drugs for the Respiratory System, by Country/Region, 2025
Figure 28: Global Market Shares of Therapies for Alzheimer’s Disease, by Country/Region, 2025
Figure 29: Global Market Shares of Epilepsy Therapeutics, by Country/Region, 2025
Figure 30: Global Market Shares of Traumatic Brain Injury Treatments, by Country/Region, 2025
Figure 31: Global Market Shares of Diabetes Drugs, by Country/Region, 2025
Figure 32: Global Market Shares of Gastrointestinal Drugs, by Country/Region, 2025
Figure 33: Global Market Shares of Implantable Devices, by Country/Region, 2025
Figure 34: Global Market Shares of Implantable Devices, by Type, 2025
Figure 35: Global Market Shares of Nanomedicine, by Country/Region, 2025
Figure 36: Global Market Shares of Nuclear Medicine, by Country/Region, 2025
Figure 37: Global Market Shares of Artificial Intelligence, by Country/Region, 2025
Figure 38: Global Market Shares of Artificial Intelligence, by Application, 2025
Figure 39: Global Market Shares of Theranostics, by Category, 2025
Figure 40: Global Market Shares of Theranostics, by Product Type, 2025
Figure 41: Global Market Shares of Therapeutic Agents Used with Companion Diagnostics, by Drug Type, 2025
Figure 42: Global Market Shares of Theranostics, by Application, 2025
Figure 43: Global Market Shares of Cancer Theranostics, by Cancer Type, 2025
Figure 44: Global Market Shares of Theranostics, by Country/Region, 2025
Figure 45: Distribution of Producers of Theranostic Technologies, by Product Type and Country/Region, 2020
Figure 46: U.S. Patent Trend of Theranostics, 2016-2020
Figure 47: Patent Shares of Theranostics, by Country/Region, 2020
Figure 48: Patent Shares of Theranostics, by Country, 2020
Figure 49: U.S. Patent Shares of Theranostics, by Patent Category, 2020
Figure 50: U.S. Patent Shares of Theranostics, by Material Type, 2020
Figure 51: U.S. Patent Shares of Theranostics, by Application, 2020

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Astrid Pharma
  • Canon Medical Systems
  • Clarity Pharmaceuticals
  • Foundation Medicine
  • Hitachi
  • Perkinelmer
  • MORE

Theranostics is a group of technologies aimed at combining diagnosis with therapy. This relatively new field of medicine is bringing numerous advantages in healthcare, including simpler medical procedures, personalized medicine, time-saving solutions, shorter hospital stays, therapies with high specificity, and treatments with reduced side effects.

The publisher has identified five main sectors in which theranostics finds current and potential applications: cardiovascular diseases (CVDs); neurological disorders; oncology; respiratory, inflammatory and infectious diseases (RIIDs); and tissue engineering.

This study provides an updated review of theranostic technologies, including materials and equipment, properties, strategies, and applications. It also offers a detailed market analysis for theranostics by segment (category, product type, application, and region), describing technical aspects and trends that will affect future growth of this market.

Sales of theranostic products are expected to rise at a double-digit rate during the next five years relevant factors that will be responsible for this growth are the following:

  • There is an increasing prevalence of cancer and cardiovascular diseases worldwide.
  • There is a greater need for less expensive and more effective treatment options for complex diseases such as cancer.
  • Streamlining of healthcare treatments is being implemented to reduce hospital stays and number of surgeries.
  • Stronger demand is projected in oncology due to the need to provide cancer patients with more advanced, less invasive, and safer treatment options.
  • A wide range of biological entities and state-of-the-art equipment are becoming commercially available for creating and guiding nanostructures characterized by higher disease specificity and less toxicity.
  • Emerging trends, including the possibility of combining various technologies to improve treatment efficacy, will help to spur growth.
Note: Product cover images may vary from those shown
  • Astrid Pharma
  • Bayer
  • Bristol Myers Squibb
  • Canon Medical Systems
  • Caris Life Sciences
  • Carl Zeiss
  • Clarity Pharmaceuticals
  • Curium Pharma
  • Encapsula Nanosciences
  • Foundation Medicine
  • GE Healthcare
  • GlaxoSmithKline
  • Hitachi
  • Magforce
  • Merck KGaA
  • Perkinelmer
  • Pfizer
  • Roche
  • Siemens Healthcare
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll